HEADER TRANSFERASE 05-FEB-04 1UWH TITLE THE COMPLEX OF WILD TYPE B-RAF AND BAY439006. COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 447-722; COMPND 5 SYNONYM: BRAF, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1, P94; COMPND 6 EC: 2.7.1.37, 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.BARFORD,S.M.ROE,P.T.C.WAN,CANCER GENOME PROJECT REVDAT 5 13-DEC-23 1UWH 1 REMARK REVDAT 4 17-JAN-18 1UWH 1 TITLE REVDAT 3 03-OCT-12 1UWH 1 HEADER COMPND SOURCE KEYWDS REVDAT 3 2 1 REMARK VERSN HETSYN FORMUL REVDAT 2 24-FEB-09 1UWH 1 VERSN REVDAT 1 19-MAR-04 1UWH 0 JRNL AUTH P.T.C.WAN,M.J.GARNETT,S.M.ROE,S.LEE,D.NICULESCU-DUVAZ, JRNL AUTH 2 V.M.GOOD,C.M.JONES,C.J.MARSHALL,C.J.SPRINGER,D.BARFORD, JRNL AUTH 3 R.MARAIS JRNL TITL MECHANISM OF ACTIVATION OF THE RAF-ERK SIGNALING PATHWAY BY JRNL TITL 2 ONCOGENIC MUTATIONS OF B-RAF JRNL REF CELL(CAMBRIDGE,MASS.) V. 116 855 2004 JRNL REFN ISSN 0092-8674 JRNL PMID 15035987 JRNL DOI 10.1016/S0092-8674(04)00215-6 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1710100.430 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 18688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 907 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2805 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4192 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 106.7 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.73000 REMARK 3 B22 (A**2) : -6.73000 REMARK 3 B33 (A**2) : 13.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.47 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.840 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.780 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.930 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 24.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : BAX4.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : BAX4.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES AT THE N AND C-TERMINI AND REMARK 3 PART OF THE ACTIVATION LOOP (600-611) ARE DISORDERED AND NOT REMARK 3 SEEN. REMARK 4 REMARK 4 1UWH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-FEB-04. REMARK 100 THE DEPOSITION ID IS D_1290014522. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9755 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18727 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.35100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BEAST REMARK 200 STARTING MODEL: PDB ENTRY 1WFC, 3LCK, 1JPA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.50500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.14000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.75250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.14000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 107.25750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.14000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.14000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.75250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.14000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.14000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 107.25750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.50500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 INVOLVED IN MITOGENIC SIGNAL TRANSDUCTION FROM REMARK 400 THE CELL MEMBRANE TO THE NUCLEUS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 600 REMARK 465 SER A 601 REMARK 465 ARG A 602 REMARK 465 TRP A 603 REMARK 465 SER A 604 REMARK 465 GLY A 605 REMARK 465 SER A 606 REMARK 465 HIS A 607 REMARK 465 GLN A 608 REMARK 465 PHE A 609 REMARK 465 GLU A 610 REMARK 465 GLN A 611 REMARK 465 LYS B 600 REMARK 465 SER B 601 REMARK 465 ARG B 602 REMARK 465 TRP B 603 REMARK 465 SER B 604 REMARK 465 GLY B 605 REMARK 465 SER B 606 REMARK 465 HIS B 607 REMARK 465 GLN B 608 REMARK 465 PHE B 609 REMARK 465 GLU B 610 REMARK 465 GLN B 611 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 612 CG CD1 CD2 REMARK 470 SER A 613 OG REMARK 470 LYS A 722 CG CD CE NZ REMARK 470 LEU B 612 CG CD1 CD2 REMARK 470 SER B 613 OG REMARK 470 LYS B 722 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 475 89.74 -169.79 REMARK 500 ASN A 485 -26.20 75.49 REMARK 500 PRO A 489 96.64 -61.08 REMARK 500 ALA A 521 176.79 -48.86 REMARK 500 PRO A 522 90.57 -19.90 REMARK 500 GLN A 523 122.76 81.22 REMARK 500 ILE A 542 -65.97 -105.84 REMARK 500 GLU A 544 73.33 36.34 REMARK 500 ARG A 574 -7.91 80.22 REMARK 500 ASP A 575 35.71 -152.63 REMARK 500 LEU A 587 115.55 -169.35 REMARK 500 THR A 588 108.67 97.64 REMARK 500 THR A 598 -165.32 -76.84 REMARK 500 ARG A 625 -122.58 -78.25 REMARK 500 MET A 626 96.36 -179.08 REMARK 500 LYS A 629 -73.79 45.58 REMARK 500 SER A 719 59.64 -90.16 REMARK 500 LEU A 720 -53.72 -130.53 REMARK 500 TRP B 475 90.13 -169.42 REMARK 500 ASN B 485 -26.23 76.10 REMARK 500 PRO B 489 96.79 -61.17 REMARK 500 ALA B 521 177.01 -48.73 REMARK 500 PRO B 522 89.79 -19.72 REMARK 500 GLN B 523 122.18 81.83 REMARK 500 ILE B 542 -65.94 -105.70 REMARK 500 GLU B 544 74.80 35.34 REMARK 500 ARG B 574 -8.58 80.05 REMARK 500 ASP B 575 36.61 -152.05 REMARK 500 LEU B 587 112.78 -174.61 REMARK 500 THR B 588 106.74 106.37 REMARK 500 THR B 598 -163.86 -70.33 REMARK 500 ARG B 625 -121.36 -72.00 REMARK 500 MET B 626 60.46 -172.32 REMARK 500 LYS B 629 -76.13 27.79 REMARK 500 LEU B 720 -55.46 -138.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1724 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BAX A 1723 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BAX B 1723 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UWJ RELATED DB: PDB REMARK 900 THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006 DBREF 1UWH A 447 722 UNP P15056 BRAF_HUMAN 447 722 DBREF 1UWH B 447 722 UNP P15056 BRAF_HUMAN 447 722 SEQRES 1 A 276 ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR VAL GLY SEQRES 2 A 276 GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL TYR LYS SEQRES 3 A 276 GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET LEU ASN SEQRES 4 A 276 VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA PHE LYS SEQRES 5 A 276 ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS VAL ASN SEQRES 6 A 276 ILE LEU LEU PHE MET GLY TYR SER THR ALA PRO GLN LEU SEQRES 7 A 276 ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER LEU TYR SEQRES 8 A 276 HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU MET ILE SEQRES 9 A 276 LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN GLY MET SEQRES 10 A 276 ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG ASP LEU SEQRES 11 A 276 LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU THR VAL SEQRES 12 A 276 LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SER ARG SEQRES 13 A 276 TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER GLY SER SEQRES 14 A 276 ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET GLN ASP SEQRES 15 A 276 LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR ALA PHE SEQRES 16 A 276 GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN LEU PRO SEQRES 17 A 276 TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE PHE MET SEQRES 18 A 276 VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER LYS VAL SEQRES 19 A 276 ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU MET ALA SEQRES 20 A 276 GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO LEU PHE SEQRES 21 A 276 PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA ARG SER SEQRES 22 A 276 LEU PRO LYS SEQRES 1 B 276 ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR VAL GLY SEQRES 2 B 276 GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL TYR LYS SEQRES 3 B 276 GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET LEU ASN SEQRES 4 B 276 VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA PHE LYS SEQRES 5 B 276 ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS VAL ASN SEQRES 6 B 276 ILE LEU LEU PHE MET GLY TYR SER THR ALA PRO GLN LEU SEQRES 7 B 276 ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER LEU TYR SEQRES 8 B 276 HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU MET ILE SEQRES 9 B 276 LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN GLY MET SEQRES 10 B 276 ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG ASP LEU SEQRES 11 B 276 LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU THR VAL SEQRES 12 B 276 LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SER ARG SEQRES 13 B 276 TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER GLY SER SEQRES 14 B 276 ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET GLN ASP SEQRES 15 B 276 LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR ALA PHE SEQRES 16 B 276 GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN LEU PRO SEQRES 17 B 276 TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE PHE MET SEQRES 18 B 276 VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER LYS VAL SEQRES 19 B 276 ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU MET ALA SEQRES 20 B 276 GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO LEU PHE SEQRES 21 B 276 PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA ARG SER SEQRES 22 B 276 LEU PRO LYS HET BAX A1723 32 HET BAX B1723 32 HET CL B1724 1 HETNAM BAX 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL) HETNAM 2 BAX PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE- HETNAM 3 BAX 2-CARBOXAMIDE HETNAM CL CHLORIDE ION HETSYN BAX SORAFENIB FORMUL 3 BAX 2(C21 H16 CL F3 N4 O3) FORMUL 5 CL CL 1- FORMUL 6 HOH *33(H2 O) HELIX 1 1 GLN A 492 ARG A 505 1 14 HELIX 2 2 LEU A 536 ILE A 542 1 7 HELIX 3 3 GLU A 548 LYS A 569 1 22 HELIX 4 4 LYS A 577 ASN A 579 5 3 HELIX 5 5 SER A 615 MET A 619 5 5 HELIX 6 6 ALA A 620 ARG A 625 1 6 HELIX 7 7 SER A 633 GLY A 651 1 19 HELIX 8 8 ASN A 660 ARG A 670 1 11 HELIX 9 9 ASP A 676 VAL A 680 5 5 HELIX 10 10 PRO A 685 LEU A 696 1 12 HELIX 11 11 LYS A 699 ARG A 703 5 5 HELIX 12 12 LEU A 705 SER A 719 1 15 HELIX 13 13 GLN B 492 ARG B 505 1 14 HELIX 14 14 LEU B 536 ILE B 542 1 7 HELIX 15 15 GLU B 548 LYS B 569 1 22 HELIX 16 16 LYS B 577 ASN B 579 5 3 HELIX 17 17 SER B 615 MET B 619 5 5 HELIX 18 18 ALA B 620 ARG B 625 1 6 HELIX 19 19 SER B 633 GLY B 651 1 19 HELIX 20 20 ASN B 660 ARG B 670 1 11 HELIX 21 21 ASP B 676 VAL B 680 5 5 HELIX 22 22 PRO B 685 LEU B 696 1 12 HELIX 23 23 LYS B 699 ARG B 703 5 5 HELIX 24 24 LEU B 705 SER B 719 1 15 SHEET 1 AA 5 ARG A 461 SER A 464 0 SHEET 2 AA 5 THR A 469 LYS A 474 -1 O VAL A 470 N ILE A 462 SHEET 3 AA 5 ASP A 478 MET A 483 -1 O VAL A 479 N GLY A 473 SHEET 4 AA 5 ALA A 525 GLN A 529 -1 O ILE A 526 N LYS A 482 SHEET 5 AA 5 PHE A 515 SER A 519 -1 N MET A 516 O VAL A 527 SHEET 1 AB 3 GLY A 533 SER A 535 0 SHEET 2 AB 3 ILE A 581 HIS A 584 -1 N LEU A 583 O SER A 534 SHEET 3 AB 3 VAL A 589 ILE A 591 -1 O LYS A 590 N PHE A 582 SHEET 1 BA 5 ARG B 461 GLY B 465 0 SHEET 2 BA 5 GLY B 468 LYS B 474 -1 O GLY B 468 N GLY B 465 SHEET 3 BA 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473 SHEET 4 BA 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482 SHEET 5 BA 5 PHE B 515 SER B 519 -1 N MET B 516 O VAL B 527 SHEET 1 BB 3 GLY B 533 SER B 535 0 SHEET 2 BB 3 ILE B 581 HIS B 584 -1 N LEU B 583 O SER B 534 SHEET 3 BB 3 VAL B 589 ILE B 591 -1 O LYS B 590 N PHE B 582 SITE 1 AC1 4 TRP A 449 ARG A 508 TRP B 449 ARG B 508 SITE 1 AC2 17 ILE A 462 VAL A 470 ALA A 480 GLU A 500 SITE 2 AC2 17 LEU A 504 LEU A 513 THR A 528 GLN A 529 SITE 3 AC2 17 TRP A 530 CYS A 531 LEU A 566 HIS A 573 SITE 4 AC2 17 PHE A 582 ILE A 591 GLY A 592 ASP A 593 SITE 5 AC2 17 PHE A 594 SITE 1 AC3 17 ILE B 462 VAL B 470 ALA B 480 GLU B 500 SITE 2 AC3 17 LEU B 504 LEU B 513 THR B 528 GLN B 529 SITE 3 AC3 17 TRP B 530 CYS B 531 LEU B 566 HIS B 573 SITE 4 AC3 17 PHE B 582 ILE B 591 GLY B 592 ASP B 593 SITE 5 AC3 17 PHE B 594 CRYST1 110.280 110.280 143.010 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009068 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009068 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006992 0.00000